Searchable abstracts of presentations at key conferences in endocrinology

ea0015s60 | Cushing's syndrome | SFEBES2008

Cushing’s syndrome: a success story?

Cox Sue

This presentation reviews the case of a 34-year-old woman diagnosed with Cushing’s syndrome.Her symptoms had been developing over an 8 years period until she was referred to the endocrine team in 2003.This review covers her progress from diagnosis to discharge in April of 2007 – a period that includes adrenalectomy, adrenal crisis, cosmetic surgery and the process of weaning off hydrocortisone.It is...

ea0038p179 | Nursing practise | SFEBES2015

Development of IT based nurse led endocrine tracking system

Cox Sue , Lissett Kate

The Endocrine service is predominantly out-patient based looking after a range of conditions with strong dependence on biochemical monitoring for clinical safety. Due to capacity demands we needed to explore the options available to facilitate safe monitoring with potential to increase capacity.The development of an IT based system allowed for the capacity increase, provided prompt communication with GP’s, improved patient safety, included a diagnos...

ea0031p368 | Thyroid | SFEBES2013

Managing Graves' disease: management involving endocrine nurse led service: experience from DGH

Aziz Aftab , Cox Sue , Dyer Rob G.

Graves’ disease is an autoimmune condition predominantly affecting middle aged women. It can be difficult to manage and consumes a lot of medical time and resources.In Torbay Hospital, we introduced endocrine nurse specialist (ENS) follow up service to reduce medical burden. This has shifted the work-load of patient care but on the other hand, has resulted in identification of great need for support and increased nurse time.We...

ea0038p375 | Reproduction | SFEBES2015

Long-term monitoring of hypogonadal men receiving intramuscular testosterone replacement: a retrospective audit

Rys Andrzej , Candan Jonathan , Cox Sue , Smith Jamie

Background: Intramuscular long acting testosterone injections are widely used, convenient form of androgen replacement in patients with hypogonadism.Aims: To evaluate the long term effects of parenteral long acting testosterone replacement on patients commenced on treatment in years 2006–2014 and adherence to monitoring undertaken by primary care after discharge from specialist service.Method: We reviewed the results of 64 pat...

ea0028p71 | Clinical practice/governance and case reports | SFEBES2012

Long-term remission of postmenopausal ovarian hyperandrogenism may occur following a period of gonadotropin-releasing hormone (GnRH) agonist therapy

Lawrence Carly , Dyke Claire , Cox Sue , Smith Jamie

Excessive ovarian androgen production developing in post-menopausal women can be associated with severe hirsutism and virilisation. In the absence of an identifiable androgen-secreting tumour, medical therapy rather than surgical removal is a potential treatment option. Despite this, the role and outcomes of medical therapy are not well characterised in this context. We present the long-term outcomes of 2 women with postmenopausal ovarian hyperandrogenism, both of whom were tr...